Skip to main content

Table 1 (abstract P257). Prevalence of co-existing AI diseases

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Outcome

JIA

<18 years

n=7883

JIA

≥18 years

n=4867

RA

≥18 years

n=286,601

Uveitis

4.44 (3.99, 4.89)

1.50 (1.16, 1.84)

0.52 (0.49, 0.55)

SLE

1.13 (0.90, 1.36)

3.10 (2.62, 3.59)

3.78 (3.71, 3.85)

Type 1 diabetes mellitus

0.79 (0.59, 0.98)

1.87 (1.49, 2.25)

1.83 (1.78, 1.88)

Chronic urticaria

1.74 (1.45, 2.03)

1.71 (1.34, 2.07)

0.71 (0.67, 0.74)

Ankylosing spondylitis

1.67 (1.39, 1.96)

1.48 (1.14, 1.82)

1.16 (1.12, 1.20)

Crohn’s disease

1.18 (0.94, 1.42)

1.62 (1.27, 1.98)

1.12 (1.08, 1.16)

Ulcerative colitis

0.44 (0.30, 0.59)

1.36 (1.03, 1.68)

0.87 (0.83, 0.90)

Sjögren’s syndrome

0.15 (0.07, 0.24)

1.29 (0.98, 1.61)

2.42 (2.36, 2.48)

Raynaud’s syndrome

0.63 (0.46, 0.81)

1.23 (0.92, 1.54)

1.12 (1.09, 1.16)

  1. Data are presented as prevalence rates, % (95% CI). SLE=systemic lupus erythematosus